CARA vs. ^GSPC
Compare and contrast key facts about Cara Therapeutics, Inc. (CARA) and S&P 500 (^GSPC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CARA or ^GSPC.
Key characteristics
| CARA | ^GSPC | |
|---|---|---|
| YTD Return | 0.96% | 11.18% |
| 1Y Return | -80.52% | 26.33% |
| 3Y Return (Ann) | -61.75% | 8.72% |
| 5Y Return (Ann) | -47.65% | 13.16% |
| 10Y Return (Ann) | -25.32% | 10.99% |
| Sharpe Ratio | -0.77 | 2.38 |
| Daily Std Dev | 107.15% | 11.54% |
| Max Drawdown | -98.22% | -56.78% |
| Current Drawdown | -97.43% | -0.09% |
Correlation
The correlation between CARA and ^GSPC is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CARA vs. ^GSPC - Performance Comparison
In the year-to-date period, CARA achieves a 0.96% return, which is significantly lower than ^GSPC's 11.18% return. Over the past 10 years, CARA has underperformed ^GSPC with an annualized return of -25.32%, while ^GSPC has yielded a comparatively higher 10.99% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CARA vs. ^GSPC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Cara Therapeutics, Inc. (CARA) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Drawdowns
CARA vs. ^GSPC - Drawdown Comparison
The maximum CARA drawdown since its inception was -98.22%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for CARA and ^GSPC. For additional features, visit the drawdowns tool.
Volatility
CARA vs. ^GSPC - Volatility Comparison
Cara Therapeutics, Inc. (CARA) has a higher volatility of 23.64% compared to S&P 500 (^GSPC) at 3.36%. This indicates that CARA's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.